Pre-/post-implantation MAFA together with the ratio R for each tested device and all acquisitions
| Device | Projection | IR | MAFApre | MAFApost | R |
|---|---|---|---|---|---|
| Solitaire AB | AP | 2 | 6.20 | 6.00 | 0.97 |
| AP | 3 | 6.00 | 5.70 | 0.95 | |
| Lateral | 2 | 5.90 | 5.50 | 0.93 | |
| Lateral | 3 | 6.90 | 6.00 | 0.87 | |
| pCONus | AP | 2 | 6.10 | 6.00 | 0.98 |
| AP | 3 | 5.90 | 5.60 | 0.95 | |
| Lateral | 2 | 5.90 | 5.10 | 0.86 | |
| Lateral | 3 | 6.10 | 5.30 | 0.87 | |
| pCANvas | AP | 2 | 6.10 | 2.60 | 0.43 |
| AP | 3 | 6.00 | 2.70 | 0.45 | |
| Lateral | 2 | 5.90 | 2.20 | 0.37 | |
| Lateral | 3 | 5.60 | 2.30 | 0.41 |
AP, anteroposterior; IR, injection rate; MAFA, mean aneurysm flow amplitude.